SCHEMBL628467

SCHEMBL628467

[CH2]CC[CH]OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264769 0.81
SCHEMBL9142337 0.79
SCHEMBL3320964 0.78
SCHEMBL11645833 0.77
SCHEMBL9148561 0.77 ALDH1A1 (0.30)
SCHEMBL5491679 0.77 ALDH1A1 (0.30)
SCHEMBL10347203 0.74
SCHEMBL3322648 0.72
SCHEMBL1039505 0.72
SCHEMBL1454622 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828362-A1 COMPOSITION OF LAUNDRY DETERGENT IMPROVING TOUCH FEEL OF CLOTHES AND MANUFACTURING METHOD THEREOF LG HOUSEHOLD & HEALTHCARE CO., LTD. (KR) 2007-09-05 EP claimed
US-20060210528-A1 Therapy for tropical diseases ASPIRE BIOTECH, INC. 2006-09-21 US claimed
WO-2006059811-A1 COMPOSITION OF LAUNDRY DETERGENT IMPROVING TOUCH FEEL OF CLOTHES AND MANUFACTURING METHOD THEREOF LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2006-06-08 WO claimed
US-6665028-B2 Gives an anisotropic scattering of a linearly polarized light and has an excellent diffusion property in a scattering direction, and that is suitable for improving visibility, brightness etc. of a liquid crystal display etc. NITTO DENKO CORPORATION (JP) 2003-12-16 US claimed
US-20030143189-A1 Therapy for topical diseases ASPIRE BIOTECH, INC. 2003-07-31 US claimed
WO-2003041686-A2 IMPROVED THERAPY FOR TOPICAL DISEASES MEDLOGIC GLOBAL LIMITED (GB) 2003-05-22 WO claimed
WO-2024106434-A1 CURABLE RESIN COMPOSITION, CURED ARTICLE AND GAP FILLER 大阪有機化学工業株式会社 2024-05-23 WO disclosed
US-20230265104-A1 NOVEL HETEROCYCLIC COMPOUNDS Prism BioLab Co., Ltd. (JP) 2023-08-24 US disclosed
EP-3604362-B1 MULTI-COMPONENT POLAR OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME JAPAN POLYETHYLENE CORP (JP) 2023-08-02 EP disclosed
WO-2023140369-A1 PHOSPHORIC ACID DERIVATIVES Prism BioLab Co., Ltd. (JP) 2023-07-27 WO disclosed
CN-116478574-A Light-converting ink composition, light-converting laminated substrate produced using same, light-converting pixel substrate, and image display device 东友精细化工有限公司 2023-07-25 CN disclosed
EP-4182317-A1 NOVEL HETEROCYCLIC COMPOUNDS PRISM BioLab Co., Ltd. (JP) 2023-05-24 EP disclosed
EP-3699985-B1 LITHIUM SECONDARY BATTERY INCLUDING ALKOXY PHOSPHINE-BASED ADDITIVE SAMSUNG SDI CO LTD (KR) 2023-05-17 EP disclosed
EP-0742211-A1 PYRIDAZINONE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1996-11-13 EP disclosed
US-5491167-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY, LIMITED (JP) 1996-02-13 US disclosed
EP-0668259-A1 A method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) 1995-08-23 EP disclosed
US-5434302-A Method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom PARADIES H HENRICH (DE) 1995-07-18 US disclosed
US-5420126-A Potassium channel activators YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-05-30 US disclosed
EP-0609058-A2 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1994-08-03 EP disclosed
EP-0432893-A2 Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1991-06-19 EP disclosed